Cell Chemical Biology

Papers
(The median citation count of Cell Chemical Biology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
CBLs downregulation foretells T cell ubiquitination leading to autoimmunity129
A versatile residue numbering scheme for Nav and Cav channels127
A covalent inhibitor targeting Cys16 on RhoA in colorectal cancer96
Voices: Challenges and opportunities in regulating the immune system96
RENBP inhibition amplifies metabolic glycan labeling efficiency of antigen-presenting cells in vitro and in vivo89
ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas87
A genome-wide CRISPR-Cas9 screen identifies CENPJ as a host regulator of altered microtubule organization during Plasmodium liver infection81
Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation79
Antisense-mediated senseful regulation of orchestrated metabolic response77
Meet the Authors: Christopher R. Mansfield and Emily R. Derbyshire77
New sheriff in town: Cyclic peptide inhibitors of a DUB module75
Therapeutic potential of inhibiting the PI3Kγ complex for leukemia75
Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 174
Heterologous characterization of mechercharmycin A biosynthesis reveals alternative insights into post-translational modifications for RiPPs71
2′-OH as a universal handle for studying intracellular RNAs71
Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine71
Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development69
Control of topoisomerase II activity and chemotherapeutic inhibition by TCA cycle metabolites68
Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistance65
Generation of an anticoagulant aptamer that targets factor V/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples64
Next steps for targeted protein degradation64
Advances in spatial proteomics: Mapping proteome architecture from protein complexes to subcellular localizations62
An interactive resource mapping the proteome and reactive cysteine landscape across the NCI-60 reveals cell and tissue-specific profiles57
FADS2-dependent fatty acid desaturation dictates cellular sensitivity to ferroptosis and permissiveness for hepatitis C virus replication56
Meet the Authors: Harkamal S. Jhajj and Peter M. Tessier55
Valence and avidity determine the agonistic activity of anti-TNFR2 nanobody fusion proteins53
PALP: A rapid imaging technique for stratifying ferroptosis sensitivity in normal and tumor tissues in situ51
Catalytic spike antibodies: A new paradigm in neutralization51
A complex puzzle: Regulation of SLFN12 RNase activity by phosphorylation50
Beyond antibiotic resistance: The whiB7 transcription factor coordinates an adaptive response to alanine starvation in mycobacteria50
Meet the Cell Chemical Biology author and newest advisory board member: Marcus Conrad49
Peptide-mediated inhibition of the transcriptional regulator Elongin BC induces apoptosis in cancer cells49
Real-time non-invasive fluorescence imaging of gut commensal bacteria to detect dynamic changes in the microbiome of live mice48
Anti-tumor effect of PD-L1-targeting antagonistic aptamer-ASO delivery system with dual inhibitory function in immunotherapy48
A potent NLRP3 inhibitor effective against both MCC950-sensitive and -resistant inflammation46
Target deconvolution with matrix-augmented pooling strategy reveals cell-specific drug-protein interactions45
Mechanisms by which microbiome-derived metabolites exert their impacts on neurodegeneration44
Metabolic tug-of-war: Microbial metabolism shapes colonization resistance against enteric pathogens44
N6-methyladenosine modification in 18S rRNA promotes tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53 axis44
A double whammy for KEAP143
BLOC-1 and BORC: Complex regulators of endolysosomal dynamics43
Visualizing Staphylococcus aureus pathogenic membrane modification within the host infection environment by multimodal imaging mass spectrometry42
Probing the binding of interleukin-23 to individual receptor components and the IL-23 heteromeric receptor complex in living cells using NanoBRET42
Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges40
PROTAC-mediated degradation of HIV-1 Nef efficiently restores cell-surface CD4 and MHC-I expression and blocks HIV-1 replication40
Pharmacological management of disease by overcoming structural adversity40
Meet the authors: Aayushi Uberoi and Elizabeth A. Grice40
The art of designed coiled-coils for the regulation of mammalian cells40
Small molecules targeting selective PCK1 and PGC-1α lysine acetylation cause anti-diabetic action through increased lactate oxidation39
Two sides of a co(i)ndensate37
Enabling inclusion and looking ahead37
A new chink in cancer’s armor: Unleashing cell death by selective PP5 inhibition37
Inter- and intra-tumoral ALDH1 heterogeneity in breast cancer identifies therapeutic opportunities for ALDH1A-specific inhibitors37
Emerging biochemical, microbial and immunological evidence in the search for why HLA-B∗27 confers risk for spondyloarthritis37
SynPull: An advanced method for studying neurodegeneration-related aggregates in synaptosomes using super-resolution microscopy36
Splicing modulators elicit global translational repression by condensate-prone proteins translated from introns36
Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome35
Behavioral control through the direct, focal silencing of neuronal activity35
Engineering ERα degraders with pleiotropic ubiquitin ligase ligands maximizes therapeutic efficacy by co-opting distinct effector ligases35
A structure-specific small molecule inhibits a miRNA-200 family member precursor and reverses a type 2 diabetes phenotype34
Two genomes, one destiny: Mitophagy at the crossroads of inheritance and disease34
Deciphering the opioid code34
HDAC3 and HDAC8 PROTAC dual degrader reveals roles of histone acetylation in gene regulation33
Natural products chlorotonils exert a complex antibacterial mechanism and address multiple targets33
Arabinose- and xylose-modified analogs of 2′,3′-cGAMP act as STING agonists33
Humanized zebrafish as a tractable tool for in vivo evaluation of pro-myelinating drugs33
Linked-domain inhibitors designed to block UBE2D induce the unfolded protein response33
Covalent inhibition of ACSL4 alleviates ferroptosis-induced acute liver injury33
Cell-free production of personalized therapeutic phages targeting multidrug-resistant bacteria33
Induced proximity in biology and therapeutics32
Boosting glycolysis to combat fragile bone in type 1 diabetes31
Screening in serum-derived medium reveals differential response to compounds targeting metabolism31
Characterization of an allosteric inhibitor of fungal-specific C-24 sterol methyltransferase to treat Candida albicans infections31
No acetyl-CoA keeps Plasmodium at bay31
S-Nitrosylation-mediated dysfunction of TCA cycle enzymes in synucleinopathy studied in postmortem human brains and hiPSC-derived neurons31
Capsaicin ameliorates inflammation in a TRPV1-independent mechanism by inhibiting PKM2-LDHA-mediated Warburg effect in sepsis30
In vivo bioluminescence imaging of labile iron in xenograft models and liver using FeAL-1, an iron-activatable form of D-luciferin30
Therapeutic induction of ferroptosis in tumors using PD-L1 targeting antibody nanogel conjugates30
Feel the breeze: Opening the therapeutic window with RIPTACs and induced proximity30
Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite30
Selective killing of the human gastric pathogen Helicobacter pylori by mitochondrial respiratory complex I inhibitors29
Plant synthetic genomics: Big lessons from the little yeast29
Mechanism-based inhibition of gut microbial tryptophanases reduces serum indoxyl sulfate29
RNATACs: Multispecific small molecules targeting RNA by induced proximity29
Mo’ m1A, mo’ problems28
D-aring to explore: New approaches to gasdermin D targeting28
PCNA degradation exhibits superior pharmacological effects over stoichiometric inhibition28
Multiple PDE3A modulators act as molecular glues promoting PDE3A-SLFN12 interaction and induce SLFN12 dephosphorylation and cell death28
Insights into lysophosphatidylserine recognition and Gα12/13-coupling specificity of P2Y1028
Meet the authors: Mitchel L. Tepe and Huiqing Zhou28
Small molecule targeting of transcription-replication conflict for selective chemotherapy28
Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators27
Structural basis of CD97 activation and G-protein coupling27
CDK2 heterobifunctional degraders co-degrade CDK2 and cyclin E resulting in efficacy in CCNE1-amplified and overexpressed cancers27
Redox proteomics combined with proximity labeling enables monitoring of localized cysteine oxidation in cells27
Transient hydroxycholesterol treatment restrains TCR signaling to promote long-term immunity26
Protomer selectivity of type II RAF inhibitors within the RAS/RAF complex26
Epigenetic fluidity meets phenotypic malleability in intestinal epithelial cells26
Discovery of a PROTAC degrader for METTL3-METTL14 complex26
An N terminomics toolbox combining 2-pyridinecarboxaldehyde probes and click chemistry for profiling protease specificity26
Mechanisms and functions of lysosomal lipid homeostasis26
A highly selective, cell-permeable furin inhibitor BOS-318 rescues key features of cystic fibrosis airway disease25
Integrating inflammatory biomarker analysis and artificial-intelligence-enabled image-based profiling to identify drug targets for intestinal fibrosis25
How to kill an ERKsome target: PROTACs deliver the deathblow25
Transcriptional restart: A new role for PARylation in overcoming DNA damage25
Identifying and antagonizing the interactions between layilin and glycosylated collagens25
The physiological and pathological roles of RNA modifications in T cells25
CRAGE-CRISPR facilitates rapid activation of secondary metabolite biosynthetic gene clusters in bacteria24
Lactylation of mTOR enhances autophagy in skeletal muscle during exercise24
The chemistry of electrical signaling in sodium channels from bacteria and beyond24
Chemoproteomic profiling of substrate specificity in gut microbiota-associated bile salt hydrolases24
Targeting selective E3 ligase for healing cardiac fibrosis24
Identification of small molecules that strongly inhibit bacterial quorum sensing using a high-throughput lipid vesicle lysis assay24
Discovery and biosynthesis of non-canonical C16-terpenoids from Pseudomonas24
Screening compound libraries for H2O2-mediated cancer therapeutics using a peroxiredoxin-based sensor24
Excited to see you: New imaging approaches to detect ferrous iron in vivo24
Targeting N-Myc in neuroblastoma with selective Aurora kinase A degraders23
Voices: Challenges and opportunities for bioorthogonal chemistry23
Targeting VPS41 induces methuosis and inhibits autophagy in cancer cells23
Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer23
CLK2 and CLK4 are regulators of DNA damage-induced NF-κB targeted by novel small molecule inhibitors23
Accelerating multiplexed profiling of protein-ligand interactions: High-throughput plate-based reactive cysteine profiling with minimal input22
PARP trapping is governed by the PARP inhibitor dissociation rate constant22
Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor22
Photo-proximity labeling in live primary neurons identifies an AMPA-receptor signal transducer in homeostatic synaptic plasticity22
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling22
Tools to investigate the cell surface: Proximity as a central concept in glycoRNA biology22
Biogenesis and roles of tRNA queuosine modification and its glycosylated derivatives in human health and diseases22
Inhibitors of the ATPase p97/VCP: From basic research to clinical applications22
Host-like conditions validate nutrient transport as an antimalarial drug target21
The liquid lectin array detects compositional glycocalyx differences using multivalent DNA-encoded lectins on phage21
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells21
Phosphorylation barcodes direct biased chemokine signaling at CXCR321
Chemically modified guide RNAs enhance CRISPR-Cas13 knockdown in human cells21
Immunity in motion: The role of mechanics in macrophage biology20
Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia20
The dark side of circular RNA, a new driver of genome instability20
Quinoline-based compounds can inhibit diverse enzymes that act on DNA20
Small-molecule allosteric inhibitors of GPX420
Addressing the Enzyme-independent tumor-promoting function of NAMPT via PROTAC-mediated degradation20
Development of D2HG biosensors inspired by the molecular mechanism of D2HG regulation of DhdR20
Inhibiting GLUTtony in cancer20
Phytate enhances gut Parasutterella colonization to alleviate radiation injury20
Bortezomib inhibits ZIKV/DENV by interfering with viral polyprotein cleavage via the ERAD pathway20
Targeted epigenetic induction of mitochondrial biogenesis enhances antitumor immunity in mouse model20
Ligand discovery by activity-based protein profiling20
METTL3: Melting the tumor microenvironment for improved immunotherapy19
Monitoring autophagic flux in vivo revealed its physiological response and significance of heterogeneity in pancreatic beta cells19
The culinary chemist: Out of the lab and into the tent19
CBX4 acetoacetylation as an inhibitory mechanism of HIF-1α activity19
A “light” touch on PI3K to interrogate cancer drug resistance19
MICU1 controls the sensitivity of the mitochondrial Ca2+ uniporter to activators and inhibitors19
Cellular reprogramming by protein degradation: The next frontier in cancer immunotherapy19
Facile generation of biepitopic antibodies with intrinsic agonism for activating tumor necrosis factor receptors19
Visualization of the dynamic interaction between nucleosomal histone H3K9 tri-methylation and HP1α chromodomain in living cells19
Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp12019
Meet the authors: Cydney N. Johnson, Shyra Wilde, Elaine Tuomanen, and Jason W. Rosch19
A sterol analog inhibits hedgehog pathway by blocking cholesterylation of smoothened19
Clionamines stimulate autophagy, inhibit Mycobacterium tuberculosis survival in macrophages, and target Pik118
New twists in anti-malarial drug resistance18
One-pot trimodal mapping of unmethylated, hydroxymethylated, and open chromatin sites unveils distinctive 5hmC roles at dynamic chromatin loci18
Meet the authors: Katerina Jones, Camila Bernardo de Brito, and Mariana Xavier Byndloss18
Small-molecule inhibitors of ferrochelatase are antiangiogenic agents18
In vivo bioluminescence imaging of granzyme B activity in tumor response to cancer immunotherapy18
Peptide passports: Programmable import fuels novel protein building blocks18
Identification of Pax protein inhibitors that suppress target gene expression and cancer cell proliferation18
Strategies of bacterial detection by inflammasomes18
STX-bpc: “Brightening” the path to neuronal inhibition18
Targeted degradation of CDK9 potently disrupts the MYC-regulated network18
Temporal resolution of gene derepression and proteome changes upon PROTAC-mediated degradation of BCL11A protein in erythroid cells18
Ligand-directed bias of G protein signaling at the dopamine D2 receptor18
Sharks give a handle to potent anti-tumor multiparatopic antibodies inducing membrane depletion of PD-L118
A proximity labeling-based orthogonal trap strategy identifies HDAC8 promotes cell motility by modulating cortactin acetylation18
A collection of chemical biology strategies for visualization in live cells17
Bivalent inhibitors of the BTB E3 ligase KEAP1 enable instant NRF2 activation to suppress acute inflammatory response17
One-carbon unit supplementation fuels purine synthesis in tumor-infiltrating T cells and augments checkpoint blockade17
Robust antitumor treatment driven by lock-and-key biorecognition of dynamic cyclic diselenide-guided chiral prodrug self-assembly17
Identification of cell wall synthesis inhibitors active against Mycobacterium tuberculosis by competitive activity-based protein profiling17
Capturing the conversion of the pathogenic alpha-1-antitrypsin fold by ATF6 enhanced proteostasis17
Targeting the MYC oncogene with a selective bi-steric mTORC1 inhibitor elicits tumor regression in MYC-driven cancers17
Activation primes GPCRs for versatile coupling17
Acylation probing of “generic” RNA libraries reveals critical influence of loop constraints on reactivity17
Recognition of the tRNA structure: Everything everywhere but not all at once17
Two birds, one stone: Non-canonical therapeutic effects of the PARP inhibitor Talazoparib17
A method for the detection and enrichment of endogenous cereblon substrates16
Specificity profiling of deubiquitylases against endogenously generated ubiquitin-protein conjugates16
The cyclimids: Degron-inspired cereblon binders for targeted protein degradation16
Pharmacologic activation of a compensatory integrated stress response kinase promotes mitochondrial remodeling in PERK-deficient cells16
Repurposing AS1411 for constructing ANM-PROTACs16
Insights into biofilm architecture and maturation enable improved clinical strategies for exopolysaccharide-targeting therapeutics16
Spatiotemporally resolved GPCR interactome uncovers unique mediators of receptor agonism16
Target protein localization and its impact on PROTAC-mediated degradation16
Ternary complex dissociation kinetics contribute to mutant-selective EGFR degradation16
TREM2 is thyroid hormone regulated making the TREM2 pathway druggable with ligands for thyroid hormone receptor16
Metabolic modulation of mitochondrial mass during CD4+ T cell activation16
Discovery of dual-active ethionamide boosters inhibiting the Mycobacterium tuberculosis ESX-1 secretion system16
Causes, functions, and therapeutic possibilities of RNA secondary structure ensembles and alternative states16
Genetically encoded tool for manipulation of ΔΨm identifies its role as the driver of ISR induced by ATP synthase dysfunction15
Hydroxyproline metabolism enhances IFN-γ-induced PD-L1 expression and inhibits autophagic flux15
Chemical genomics reveals targetable programs of human cancers rooted in pluripotency15
Targeted elimination of mutated mitochondrial DNA by a multi-functional conjugate capable of sequence-specific adenine alkylation15
Discovery of compounds that reactivate p53 mutants in vitro and in vivo15
A selective PPM1A inhibitor activates autophagy to restrict the survival of Mycobacterium tuberculosis15
High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface14
Platelets accelerate lipid peroxidation and induce pathogenic neutrophil extracellular trap release14
Ligand-induced assembly of antibody variable fragments for the chemical regulation of biological processes14
Profiling of drug resistance in Src kinase at scale uncovers a regulatory network coupling autoinhibition and catalytic domain dynamics14
CysDB: a human cysteine database based on experimental quantitative chemoproteomics14
Generation of glycan-specific nanobodies14
The hydrophobicity of the CARD8 N-terminus tunes inflammasome activation14
Identification of an endoplasmic reticulum proteostasis modulator that enhances insulin production in pancreatic β cells14
Context-dependent regulation of ferroptosis sensitivity14
Engineering acyclovir-induced RNA nanodevices for reversible and tunable control of aptamer function14
Degrading the signal amplifier: ITK as a target for targeted protein degradation14
Genetically incorporated crosslinkers identify regulators of membrane protein PD-L1 in mammalian cells14
Chemical approaches to unraveling the biology of mycobacteria14
Regulation of bacterial gene expression by non-coding RNA: It is all about time!14
Sensing within: Mitochondrial inside-out signal transduction14
RPL22 links ribosome biogenesis, RNA splicing, and sensitivity to RNA polymerase I inhibition14
Endogenous anti-tumorigenic nitro-fatty acids inhibit the ubiquitin-proteasome system by directly targeting the 26S proteasome14
Meet the authors: Xueqin Jin, Jian Huang, Huan Wang, Kan Wang, and Nieng Yan13
3D two-photon brain imaging reveals dihydroartemisinin exerts antiepileptic effects by modulating iron homeostasis13
When CDK4/6i meets GPX4i: Stop dividing to die iron hard13
Engineering affinity-matured variants of an anti-polysialic acid monoclonal antibody with superior cytotoxicity-mediating potency13
Raf protomers: Drug binding preferences in living cells13
Modifying the antiviral innate immune response by selective writing, erasing, and reading of m6A on viral and cellular RNA13
A sticky situation for targeted cancer therapy13
Pantothenate kinase is an effective target for antifungal therapy13
Site-resolved assessment of targeted protein degradation13
Localization matters in targeted protein degradation13
ND3 Cys39 in complex I is exposed during mitochondrial respiration13
A base editor facilitates simultaneous purine and pyrimidine substitutions for ex vivo and in vivo mutagenesis screens13
Engineering electrogenetic interfaces for mammalian cell control12
Glycopeptidolipid glycosylation controls surface properties and pathogenicity in Mycobacterium abscessus12
Targeting type I DED interactions at the DED filament serves as a sensitive switch for cell fate decisions12
Disruption to the gut microbiome by non-antibiotics is linked to infection risk12
Proteomics from compartment-specific APEX2 labeling in Mycobacterium tuberculosis reveals Type VII secretion substrates in the cell wall12
Therapeutic potency of compound RMY-205 for pulmonary fibrosis induced by SARS-CoV-2 nucleocapsid protein12
Integration of metabolism and regulation reveals rapid adaptability to growth on non-native substrates12
Investigating the NRAS 5′ UTR as a target for small molecules12
Mixed alkyl/aryl phosphonates identify metabolic serine hydrolases as antimalarial targets12
Structural basis for antibody-mediated neutralization of lymphocytic choriomeningitis virus12
Getting in on the action: New tools to see SARS-CoV-2 infect a cell12
AGC kinase inhibitors regulate STING signaling through SGK-dependent and SGK-independent mechanisms12
Inhibiting cancer metastasis with water-solubilized membrane receptor CXCR4QTY-Fc as a molecular trap12
Cell-selective bioorthogonal labeling12
Inducible mismatch repair streamlines forward genetic approaches to target identification of cytotoxic small molecules12
The next Nobel Prize in chemistry or in physiology or medicine12
Multiplex miRNA reporting platform for real-time profiling of living cells12
Proteasome inhibitors: The next generation of antimalarial drugs?12
0.32850313186646